About: Why have nanotechnologies been underutilized in the global uprising against the coronavirus pandemic?

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Why have nanotechnologies been underutilized in the global uprising against the coronavirus pandemic? Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : covidontheweb.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Why have nanotechnologies been underutilized in the global uprising against the coronavirus pandemic?
Creator	Uskoković, Vuk
Source	Medline; PMC
abstract	Prior research on nanotechnologies in diagnostics, prevention and treatment of coronavirus infections is reviewed. Gold nanoparticles and semiconductor quantum dots in colorimetric and immunochromatographic assays, silica nanoparticles in a polymerase chain reaction and spike protein nanospheres as antigen carriers and adjuvants in vaccine formulations present notable examples in diagnostics and prevention, while uses of nanoparticles in coronavirus infection treatments have been merely sporadic. The current absence of antiviral therapeutics that specifically target human coronaviruses, including SARS-CoV-2, might be largely due to the underuse of nanotechnologies. Elucidating the interface between nanoparticles and coronaviruses is timely, but presents the only route to the rational design of precisely targeted therapeutics for coronavirus infections. Such a fundamental approach is also a viable prophylaxis against future pandemics of this type.
has issue date	2020-05-28(xsd:dateTime)
bibo:doi	10.2217/nnm-2020-0163
bibo:pmid	32462968
has license	cc-by
sha1sum (hex)	eeccfa5076f26c0dab1f79e287d64d658586e550
schema:url	https://doi.org/10.2217/nnm-2020-0163
resource representing a document's title	Why have nanotechnologies been underutilized in the global uprising against the coronavirus pandemic?
has PubMed Central identifier	PMC7265684
has PubMed identifier	32462968
schema:publication	Nanomedicine
resource representing a document's body	covid:eeccfa5076f26c0dab1f79e287d64d658586e550#body_text
is schema:about of	named entity 'coronavirus' named entity 'silica' named entity 'prevention' named entity 'SPORADIC' named entity 'CURRENT' named entity 'ABSENCE OF' named entity 'PRESENT' named entity 'TYPE' named entity 'HUMAN' named entity 'TARGET' named entity 'SARS-COV-2' named entity 'VIABLE' named entity 'NANOSPHERES' named entity 'NANOTECHNOLOGIES' named entity 'chain reaction' named entity 'coronaviruses' named entity 'human coronaviruses' named entity 'rational design' named entity 'antiviral' named entity 'semiconductor' named entity 'coronavirus infection' named entity 'precisely' named entity 'graphene' named entity 'virology' named entity 'pharmacotherapies' named entity 'virus' named entity 'virus' named entity 'receptor' named entity 'coronaviruses' named entity 'surface plasmons' named entity 'modern technologies' named entity 'MERS-CoV' named entity 'electron transfer' named entity 'nanoparticle' named entity 'nanoparticle' named entity 'SARS-CoV-2' named entity 'molecular biology' named entity 'TMPRSS2' named entity 'IFN-γ' named entity 'solvent' named entity 'mammals' named entity 'nanotechnologies' named entity 'peptide' named entity 'SARS-CoV-2' named entity 'nanotechnologies' named entity 'MERS-CoV' named entity 'amino acid residues' named entity 'nanoparticle' named entity 'recombinant' named entity 'nanoparticles' named entity 'nanoparticles' named entity 'vaccine' named entity 'fundamental interactions' named entity 'PEDV' named entity 'surface charge' named entity 'antigen' named entity 'virulence' named entity 'IBV' named entity 'gold nanoparticles' named entity 'chitosan' named entity 'immunological functions' named entity 'monoclonal antibody' named entity 'nanotechnology' named entity 'hepatitis' named entity 'SARS-CoV-2' named entity 'Middle East' named entity 'nanoparticles' named entity 'cytokines' named entity 'PEDV' named entity 'antigen' named entity 'protein' named entity 'antibody' named entity 'quantum dot' named entity 'antiviral' named entity 'nanoparticles' named entity 'kDa' named entity 'Gold nanoparticles' named entity 'patent world' named entity 'filtration' named entity 'nanoparticle' named entity 'PEDV'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software